August 4, 2016 Paul E. Freiman Port Chester, NY 10573 Re: Director Separation AgreementDirector Separation Agreement • August 5th, 2016 • Neurotrope, Inc. • Pharmaceutical preparations • New York
In connection with your resignation from the Board of Directors of Neurotrope, Inc. (the "Company") effective as of August 4, 2016 (the “Effective Date”), you and the Company have agreed to the following:
SEPARATION AGREEMENTSeparation Agreement • August 5th, 2016 • Neurotrope, Inc. • Pharmaceutical preparations • New York
This SEPARATION AGREEMENT (the “Agreement”), dated as of August 4, 2016 (the “Notice Date”) and effective as of the Effective Date (as defined in this Agreement), is made by and between Neurotrope, Inc., a Nevada corporation and its operating subsidiary, Neurotrope BioScience, Inc., a Delaware corporation (collectively, the “Company”), and Charles S. Ramat (“Executive”).
COMPANY CONSULTING AGREEMENTConsulting Agreement • August 5th, 2016 • Neurotrope, Inc. • Pharmaceutical preparations • New York
CONSULTING AGREEMENT effective as of August 4, 2016 between NEUROTROPE, INC., a Nevada corporation, having a mailing address at 50 Park Place, Suite 1401, Newark, New Jersey 07102 (the “Company”) and SM CAPITAL MANAGEMENT, LLC, a Delaware limited liability company (“Consultant”).
